NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Amphenol (APH) rated new Buy at Keybanc. $55 price target. Company can continue to deliver solid growth, augmented by acquisitions.HomeAway (AWAY) upgraded at Pacific Crest from Sector Perform to Outperform, Pacific Crest said. $31 price target. Company has a large market opportunity. International Rectifier (IRF) upgraded at JMP from Market Perform to Outperform. $25 price target. Sales will likely bottom out in the current quarter. Netflix (NFLX - Get Report) downgraded at Citigroup from Buy to Neutral. $95 price target. Dramatic ramp up in international expansion and two major execution errors.
STOCK COMMENTS / EPS CHANGESAmerican Eagle (AEO - Get Report) numbers raised at Goldman. Shares of AEO now seen reaching $18, according to Goldman Sachs. Estimates also increased, given better sales momentum. Buy rating. American Eagle estimates raised at UBS through 2013. Top line is back but concerns remain over margins. Maintain $14 price target and Neutral rating. Aeropostale (ARO - Get Report) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Failed to meet Thanksgiving expectations. Outperform rating. Avago Technologies (AVGO) estimates lowered at Jefferies through 2012. Downside risk to industrial and wired forecast. Buy rating. Baxter (BAX) estimates, target cut at Morgan Stanley. Shares of BAX now seen reaching $60, according to Morgan Stanley. Estimates also reduced, following recent meetings with management. Buy rating. Express (EXPR - Get Report) estimates, target boosted at Brean Murray. Shares of EXPR now seen reaching $29, according to Brean Murray. Estimates also upped, as the company has solid merchandising well and is expanding its customer base. Buy rating. Express estimates increased at UBS through 2013. Ability to win on comp and margin. Maintain $26 price target and Buy rating. Finisar (FNSR) estimates lowered at Jefferies through 2012. Quarter slightly below expectations. Buy rating. Guess (GES) numbers lowered at Jefferies. Shares of GES now seen reaching $55. Estimates also lowered on conservative guidance. Buy rating. Guess estimates, target reduced at Sterne Agee. Shares of GES now seen reaching $50. Estimates also cut, to match the company's new guidance. Buy rating. Hospira (HSP - Get Report) estimates lowered at Citigroup through 2012. Manufacturing issues appear increasingly problematic. Maintain $30 price target and Neutral rating. Johnson Controls (JCI) estimates cut at Morgan Stanley through 2013, Morgan Stanley said. Company is leveraged to weaker macro conditions. Overweight rating and $48 price target. Marathon Petroleum (MPC) estimates increased at Morgan Stanley through 2013. Company held an upbeat analyst meeting, highlighting growth prospects. Overweight rating and $53 price target. Rovi (ROVI - Get Report) estimates, target reduced at Morgan Stanley. Shares of ROVI now seen reaching $34, according to Morgan Stanley. Estimates also cut, to match the company's new guidance. Equal-weight rating. United Natural Foods (UNFI) target raised at Jefferies. Shares of UNFI now seen reaching $44. Gross margins will begin to stabilize. Buy rating. UnitedHealth Group (UNH) numbers raised at Oppenheimer. UNH estimates raised through 2012, Oppenheimer said. Several growth opportunities will lead to EPS accretion. Perform rating. Yum Brands (YUM - Get Report) numbers upped at BofA/Merrill. YUM estimates were boosted through 2013. Company will likely see higher sales growth in China. Buy rating and new $67 price target.
STRATEGY CALLS / MARKET CALLSPanasonic (PC) forecast cut at JP Morgan. PC unit sales forecast was reduced because of lower disk-drive supply, according to JP Morgan.
>To submit a news tip, email: email@example.com.
Follow TheStreet on Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.